Skip to the page

Data / Drug companies / Albuterol

Albuterol: 8 companies and 15 products in the FDA NDC directory

Albuterol is listed in the FDA National Drug Code Directory by 8 companies, with 15 products in commercial distribution. 15 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; solution, and the newest product started marketing on October 7, 2022.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
8
Products
15
Generic (ANDA) products
15 (100.0%)
Application numbers
5
Routes
Oral, Respiratory (inhalation)
openFDA record search
api.fda.gov

Companies that list albuterol

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Amneal Pharmaceuticals NY LLC2tabletGeneric drugs (ANDA)May 24, 2018
Aurobindo Pharma Limited2tabletGeneric drugs (ANDA)May 14, 2020
Mylan Pharmaceuticals Inc.2solutionGeneric drugs (ANDA)October 7, 2022
Proficient Rx LP2tabletGeneric drugs (ANDA)June 29, 2018
Rising Pharma Holdings, Inc.2tabletGeneric drugs (ANDA)June 29, 2018
Zydus Lifesciences Limited2tabletGeneric drugs (ANDA)October 23, 2020
Zydus Pharmaceuticals USA Inc.2tabletGeneric drugs (ANDA)October 23, 2020
Bryant Ranch Prepack1tabletGeneric drugs (ANDA)June 29, 2018

Dosage forms

Dosage formProductsShare
Tablet1386.7%
Solution213.3%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)15100%

Pharmacologic classes

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.